Fast, Capital-Efficient Companies with Innovative Vascular Treatments
We’re accelerating lean and nimble interventional vascular companies that are developing devices for addressable markets of over $10 billion.
![Intravascular Lithotripsy Device](https://assets-global.website-files.com/62a2c4be05356c6aaa3aa4cc/62a68e185d5fdfaac7e54f21_intravascular-lithotripsy-device.png)
FastWave is Rapidly Building Better IVL Catheters
The FastWave team is building cost-effective intravascular lithotripsy (IVL) balloon catheters engineered to cross difficult lesions with superior pushability and smooth performance. Big Sky partners rocketed FastWave to a $12M Series A round of financing within 6 months of forming the company.
![Venous Laser Treatment](https://assets-global.website-files.com/62a2c4be05356c6aaa3aa4cc/62a68e187f5d4d5940aa7086_venous-laser-treatment.jpg)
Crossfire’s Differentiated Approach to Thermal & NTNT Catheters
Crossfire’s exceptional team is accelerating the development of non-thermal, non-tumescent (NTNT) catheters and an economic thermal endovenous ablation system that’s optimized for procedural efficiency. Incubated out of Big Sky, Crossfire is poised for regulatory clearance and commercial launch at a record-breaking pace.